We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Evgen Pharma Plc | LSE:EVG | London | Ordinary Share | GB00BSVYN304 | ORD 0.25P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.80 | 0.75 | 0.85 | 0.80 | 0.80 | 0.80 | 1,405,000 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 422k | -4.04M | -0.0147 | -0.54 | 2.2M |
Date | Subject | Author | Discuss |
---|---|---|---|
29/4/2018 21:33 | No bother, but if your following top info, you may notice that the or top was 20p to get back in, and last chances at 18p. So overall not expecting any drops to 15p.I also noted the 98k share buy at 18 after close, so I am expecting a rise back up. But let's see how this plays out tomorrow/rest of the week.Gla | l0ngterm | |
29/4/2018 20:47 | Thx long term At least u can spot that topinfo bought and tipped evgBerney is a little thick!! Lol | nico115 | |
29/4/2018 20:45 | Berney u r the lowlife liar Turn on Twitter and read ...Topinfo tipped these ..end of I'm downgrading my tgt to 15p | nico115 | |
29/4/2018 20:09 | In addendum, plenty like me, wanted in and we got in. Which clearly shows there is a market, a focus on the company and folk are paying attention. All of which is good news as far as I am concerned in relation to where this is heading. All supported by the volume, and speed that this share moved. | l0ngterm | |
29/4/2018 20:06 | Folks it's a bit early on for all this is it not. I bought in and had a target amount to purchase, as this share is obviously under valued. I also looked at top info on twitter, and as I said previously lots of folk have an eye on this share, and top info was given a recommendation to buy. Subsequently this individual is stating what we all know, and is just trading. But let's be honest, nothing on twitter or here influenced my purchase or target. | l0ngterm | |
29/4/2018 19:45 | Nico you're just another shameless little lowlife liar. Now crawl back under your rock you pathetic excuse for pond life | bernymadoff | |
29/4/2018 18:49 | Berney I know for a fact 100pct that topinfo tipped evg a few times on Friday Don't have to price anything to you Im sure you are capable of logging into Twitter to see for yourself I will await an apology Papillon Some odd characters here !! | nico115 | |
29/4/2018 17:24 | It will be interesting to see where the share price goes next week given last weeks moves. I am a "buy and hold" investor and I am hopeless at getting the timing right. However, I do know what news is expected over the next 12 months; 1. Interim read of the P2 Breast Cancer trial in the next 2 months. 2. Full readout around Dec 2018 (market size for indication: $5 billion) 3. Full readout of SAH P2 trial expected around Q1 2019 orphan status (market size $1 billion) 4. News on the Charity funded research by Christies Manchester in triple negative breast cancer and SFX-01 5. Kings London may have results on Stroke research with SFX-01 and may announce trial early 2019 6. Possible licencing after Interim read suggested for by paid research note 7. Franklin was in the US Orphan Indication conference last week and had a slot in the "pitch and partner" section so may have licencing in SAH within 12 months or sooner 8. Autism and SFX-01 research with St Thomas's possible in next 12 months 9. Brain Cancer and SFX-01 research with a partner in the next 12 months possible 10. Huge amount of independent research to be published over the next 12 month in Sulforaphane ( perhaps 300 papers at the current rate?) I am sure I have missed some expected news. At a market cap of £16m , current price of 18p and price target of 113p by Northlands it is an interesting time. Good luck to those hoping for short term ups and downs! I have no idea. | pdt | |
29/4/2018 16:27 | nico115. I upset moneytree around 6 weeks ago by calling him a ramper and a pumper and dumper and since then he's been "stalking" me by posting immediately after me wherever I post. I did have him on filter for around 6 weeks, but took him off filter yesterday just to see what he was posting. I'd never heard of EVG until I saw he'd been posting on this bb. I agree that unfortunately one can't trust what some people post on these bb's so did moneytree did almost double his money on EVG? We only have his word for that. It could be true, or it could be a fib? Only he knows for definite. I don't follow many shares; just a few in fact and EVG wasn't one of them. I see another bio share I'd never heard of, FARN, gets a mention in today's S.Times as it has a phase III trial result imminent. The FARN share price is 830p and the Mkt Cap is £250m. I don't know if that's good value, or not. I imagine the FARN share price will either spike up, or collapse down, depending on the phase III trial result. Best of luck with EVG. I have no idea whether the current share price of 17.50p is good value, or not, since I know absolutely nothing about the company. | papillon | |
29/4/2018 16:19 | So having being given several opportunities to provide proof of the alleged Twitter ramp Nicholas has failed to provide any shred of evidence let alone a link. I rest my case. | bernymadoff | |
29/4/2018 16:18 | So having being given several opportunities to provide proof of the alleged Twitter ramp Nicholas has failed to provide any shred of evidence let alone a link. I rest my case. | bernymadoff | |
29/4/2018 09:23 | Hilarious papillonThat the problem here ..Rampers RAMP to sellWhy else would Berney come on here puffing? He THAT nice he wants posters he doesn't know to make money?It's cos he ,like topinfo ,tip and sell...blatant And then pretends he can't see topinfo ramping on Twitter...mustve mentioned evg at least 5 times!!Papillon and Dave ..lets ignore Berney..he will be desperate to sell at 18p this weekLong term evg are fine Short term more weakness to come ... | nico115 | |
28/4/2018 23:54 | moneytree1 27 Apr '18 - 08:22 - 166 of 211 0 0 0 that's me out from 12.6 glh >>>>> Congratulations are in order, moneytree. Excellent timing. Credit where credit is due. You almost doubled your money in less than a month. | papillon | |
28/4/2018 22:28 | For the 3rd time show us the proof or shut it | bernymadoff | |
28/4/2018 22:08 | Don't be so lazy Look up topinfo He tipped evg many times on Friday You are either thick or a liar Probably bothDavid,do me a favour and look up topinfo on Twitter and shut this Berney up.. | nico115 | |
28/4/2018 22:03 | For the 2nd time please post the link to the relevant tweet. You won't becauee no such tweet exists certainly not in the recent past. | bernymadoff | |
28/4/2018 22:02 | For the 2nd time please post the link to the relevant tweet. You won't becauee no such tweet exists certainly not in the recent past. | bernymadoff | |
28/4/2018 22:02 | IMM also had a multi million dollar market and crashed Name me 3 Uk smaller drug companies that have made it ..I so wish more would to save sufferers Motif passed phase 3 and they are lower than when they floated!!As I've said I like evg but topinfo ramped it and lots of selelrs around Friday Nice try Bernie !!You are a P and Dumper | nico115 | |
28/4/2018 21:56 | Berney madoffU r worse than madoffTopinfo tipped evg loads of times!!He is normally right for a day Tipped flow at 1p and now bust!!I like evg but 15p first as too much hot money in it | nico115 | |
28/4/2018 21:53 | Hardman haha they are paid to write so they aren't exactly going to be bearish Look at IMM ..collapsed Look at summit and Pli and ValV few drug companies make it I like evg but it's been ramped Now Berney would you like a eager that topinfo didn't mention and ramp evg on thurs/Friday?Wanna grand on it??Now stop lying and stop rampingDave u can adjudicate ..look up topinfo | nico115 | |
28/4/2018 21:46 | You seem to be talking it | dave444 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions